Michael A. Chambers's most recent trade in Sarepta Therapeutics Inc was a trade of 16,875 Common Stock done . Disclosure was reported to the exchange on June 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics Inc | Michael A. Chambers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 16,875 | 27,535 (0%) | 0% | - | Common Stock | |
| Sarepta Therapeutics Inc | Michael A. Chambers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 4,792 | 4,792 | - | - | Stock Options (right to buy) | |
| Sarepta Therapeutics Inc | Michael A. Chambers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 2,383 | 10,660 (0%) | 0% | - | Common Stock |